Results 241 to 250 of about 325,248 (362)
Design and Performance Analysis of an RIS-Empowered RM-DCSK System for Wireless Powered Communication. [PDF]
Liu F, Ma J, Yu Q.
europepmc +1 more source
A reconfigurable physical unclonable function is developed using CMOS‐integrated SOT‐MRAM chips, leveraging a dual‐pulse strategy and offering enhanced environmental robustness. A temperature‐compensation effect arising from the CMOS transistor and SOT‐MTJ is revealed and established as a key prerequisite for thermal resilience.
Min Wang +7 more
wiley +1 more source
A Deep Learning-Assisted Multi-Relay DCSK Communication System. [PDF]
Huang T, Hong S, Chen J, Kang L.
europepmc +1 more source
A temporally controlled drug release coating is developed for abutments using a superhydrophobic coating self‐assembled on mesoporous silica. This surface provides sequential functionality: initial contamination resistance through non‐wetting, followed by controlled drug release via wettability transition.
Zhongchao Wang +8 more
wiley +1 more source
Optimized weight spectrum method for interference signal separation in FSO communication. [PDF]
Duan Z, Qiang S, Zhao H, Wang Y.
europepmc +1 more source
Abstract INTRODUCTION Neurodegenerative diseases often involve overlapping alpha‐synuclein (asyn), amyloid beta, and tau proteinopathies, yet the mechanisms, impact, and directionality of their interactions remain unclear. METHODS We induced brain‐wide neuronal asyn/tau pathologies via viral expression of wild‐type asyn, mutant asynE46K, mutant ...
Benjamin E. Rabichow +7 more
wiley +1 more source
SLM-based PAPR reduction for improved performance of DCO-OFDM LiFi using blind estimation for healthcare monitoring system. [PDF]
Sharaf AA +3 more
europepmc +1 more source
ABSTRACT Background and Purpose The treatment of glioblastoma remains a major clinical challenge, largely due to intrinsic and acquired resistance to Temozolomide (TMZ). We aim to advance a novel therapeutic approach to overcome TMZ resistance in human glioblastoma by using the neuronal nitric oxide synthase inhibitor BA‐101 as both a monotherapy and ...
Mallikarjuna Nimgampalle +4 more
wiley +1 more source
Variations in DNA Repair Genes and Intratumoral Genetic Heterogeneity in Temozolomide-Resistant Glioblastoma. [PDF]
Chen W, Li C, Liu Y, Huang H.
europepmc +1 more source
ABSTRACT Genomic sequencing has made precision oncology of pancreatic ductal adenocarcinoma (PDAC) feasible and is recommended by numerous clinical guidelines. The clinical significance of genomic alterations in PDAC remains to be revealed. This study was designed to bridge this gap by elucidating the clinical relevance of genomic profiling in a ...
Mingwei Dong +11 more
wiley +1 more source

